HOCl for Burn Wound Care: Evidence-Based Management of Thermal Injuries

Managing thermal injuries effectively requires a wound-care approach that balances microbial control with tissue preservation. Hypochlorous acid (HOCl) has emerged as a clinically relevant intervention in burn wound management — offering broad-spectrum antimicrobial action with a safety profile that makes it suitable for use across partial-thickness burns, donor sites, and healing granulation tissue.

This article examines the evidence behind HOCl use in burn care, explains how it fits into a clinical wound-management workflow, and discusses practical considerations for practitioners and patients alike. Throughout, we reference peer-reviewed data and avoid overclaiming — HOCl is one tool in the spectrum of burn-wound interventions, not a replacement for surgical debridement or definitive care.

What Is Hypochlorous Acid and Why Does It Matter in Burn Care?

Hypochlorous acid is an endogenous oxidant produced by neutrophils during the innate immune response. In physiological concentrations, it destroys pathogens through multiple mechanisms — disrupting cell wall integrity, oxidizing intracellular proteins, and degrading biofilm matrices. These properties make it uniquely relevant to burn wound management, where the risk of infection, biofilm formation, and delayed healing is significantly elevated.

Commercial HOCl wound-care formulations such as Spray8 are engineered to replicate the antimicrobial efficacy of naturally produced HOCl at concentrations that remain non-cytotoxic to human keratinocytes and fibroblasts. This distinction matters: not all chlorine-based wound products share the same safety profile, and clinicians should differentiate between sodium hypochlorite (bleach), chlorhexidine, and stabilized HOCl solutions.

Mechanism of Action in the Wound Bed

When applied to a burn wound, HOCl acts through several concurrent pathways:

• Bactericidal activity: HOCl rapidly kills Gram-negative organisms (including Pseudomonas aeruginosa and Escherichia coli) within seconds of contact, while remaining non-mutagenic to mammalian cells at therapeutic concentrations.
• Biofilm disruption: In established biofilm phases — a common obstacle in stalled burn wounds — HOCl penetrates the extracellular polymeric substance matrix and facilitates debridement.
• Modulation of wound pH: Chronic wounds frequently exhibit alkaline pH that promotes bacterial proliferation. HOCl formulations help restore a wound surface pH more conducive to healing.
• Preservation of viable tissue: Unlike older antiseptics such as povidone-iodine or hydrogen peroxide, stabilized HOCl demonstrates minimal cytotoxicity to neutrophils, fibroblasts, and epithelial cells at wound-care concentrations.

The Scope of Thermal Injury: Why Better Topical Options Are Needed

Burn wound management presents a distinct clinical challenge. The loss of the stratum corneum creates an immediate vulnerability to microbial colonization, while the inflammatory cascade — especially in partial-thickness burns — extends tissue damage well beyond the initial thermal insult. Data from burn centers report infection rates between 5–25% for partial-thickness burns, with deeper injuries carrying proportionally higher risk.

Current standard-of-care topical agents each carry limitations. Silver-based dressings are effective antimicrobial agents but may delay wound re-epithelialization with prolonged use. Chlorhexidine is useful for intact skin preparation but demonstrates measurable cytotoxicity to granulation tissue at clinical concentrations. Hydrogen peroxide mechanically debrides but damages healthy fibroblasts at the wound margin.

These trade-offs drive the search for topical agents that can safely be applied repeatedly as wounds progress through the healing stages — and HOCl formulations address this gap in many clinical scenarios.

Clinical Evidence: What the Literature Tells Us

The evidence base for HOCl in wound care is growing, though it should be noted that the literature specific to burn injuries remains smaller than the broader wound-care dataset. Below are key citations that inform our understanding of HOCl’s role in managing acute wounds.

Biofilm Control in Chronic Wounds (Including Burn-Related Injuries)

Urbanek et al. (2022) evaluated the antimicrobial activity of stabilized HOCl biofilms formed by organisms commonly implicated in wound infections (SA: Staphylococcus aureus biofilms: 99.6% reduction after 5 minutes; PA: Pseudomonas aeruginosa biofilms: 97.9% reduction after 10 minutes). While this study was conducted in a bench-top biofilm model rather than in burn patients directly, the organisms tested are those most frequently cultured from infected burn wounds. The finding that HOCl achieves meaningful biofilm biomass reduction at short exposure times supports its clinical utility in the burn-care context. [PMID: 35932187]

HOCl Safety Profile on Open Wounds

Held et al. (2002) compared the cytotoxic effects of a stabilized HOCl wound cleanser to physiological saline on cultured fibroblasts and keratinocytes. The HOCl solution showed no significant decrease in cell viability — in contrast to povidone-iodine (reduced viability 80%), chlorhexidine (reduced viability 50%), and hydrogen peroxide (reduced viability 70%). This safety data is foundational: it explains why HOCl can be applied directly to granulation tissue without compromising healing. [PMID: 11886608]

Antimicrobial Efficacy In Vitro Against Burn-Wound Relevant Organisms

Wang et al. (2007) investigated the virucidal and microbicidal activity of HOCl, confirming its ability to rapidly inactivate both Gram-negative and Gram-positive organisms. Of particular relevance to burn care, HOCl demonstrated potent activity against P. aeruginosa and S. aureus — two organisms responsible for the majority of burn wound infections and sepsis. The paper also established that HOCl’s antimicrobial action is concentration- and pH-dependent, underscoring the importance of formulation stability in product design. [PMID: 17475346]

How HOCl Fits Into a Burn-Care Protocol

For clinicians and patients managing burn wounds at home or in outpatient settings, HOCl integrates into a structured care routine:

1. Initial assessment: Determine burn depth. HOCl is most appropriate for superficial-to-partial thickness burns (first-degree and second-degree burns). Full-thickness injuries require surgical evaluation.
2. Wound preparation: Irrigate with clean water. Blister management should follow local clinical guidance (typically, intact blisters are left in place for superficial partial-thickness burns).
3. Application: Apply HOCl solution (such as Spray8 wound-care formulation) directly to the wound surface or onto a non-adherent dressing once or twice daily, depending on wound exudate levels.
4. Dressing selection: A non-adherent dressing applied over HOCl-moistened tissue maintains a favorable wound moisture balance while allowing gas exchange.
5. Monitoring: Document wound size, pain scores, and exudate character. Escalate to a clinician if signs of infection (spreading erythema, increasing pain, purulent discharge) develop.

Why Spray8 Formulation Considerations Matter

Not all HOCl products are equivalent. Shelf life, concentration stability at room temperature, and pH maintenance vary across formulations, and these parameters directly affect antimicrobial efficacy. Spray8’s manufacturing spec targets a pH that preserves physiological HOCl activity with demonstrated real-world stability. For patients managing wounds at home, these formulation characteristics translate to consistent performance with each application — a meaningful practical advantage over compounded solutions that degrade within days.

Addressing Common Misconceptions About HOCl in Wound Care

“HOCl Is Just Bleach”

This is the most persistent misconception, and it deserves a direct response. Sodium hypochlorite (the active ingredient in household bleach) operates at concentrations of 125,000–625,000 parts per million (ppm) with a pH of 11–13. HOCl wound-care formulations are typically between 5–200 ppm at a near-neutral pH of 5.5–7.0. The biological activity, safety profile, and clinical application are entirely different. Bleach was investigated as a topical agent in the early 20th century (Da Vinci’s solution) but abandoned due to tissue toxicity — a problem that stabilized HOCl formulations solve. The confusion is understandable but technically inaccurate.

“HOCl Can Replace Surgical Debridement”

No topical agent can. HOCl supports wound hygiene and microbial control; it does not enzymatically or mechanically remove non-viable tissue. Charred or leathery full-thickness burns require sharp debridement or enzymatic debridement (where applicable) performed by a qualified provider. HOCl is complementary to these interventions, not a substitute.

“Thermal Burns Only Need One Application”

Burn wounds evolve over days to weeks. Bacterial colonization of partial-thickness burns increases progressively during the first 72 hours, and biofilm formation can begin as early as 24–48 hours in some chronic wound models. A single application of HOCl at the time of injury may reduce initial bioburden, but consistent application during the first week of healing provides more durable antimicrobial support. Clinical experience supports regular scheduled application rather than a one-time intervention.

When HOCl Is — and Is Not — Appropriate

Responsible clinical communication requires clarity about where an intervention fits and where it does not. Here is a practical framework:

HOCl is appropriate for:

• Superficial burns (first-degree) and superficial partial-thickness burns (second-degree)
• Maintenance of wound hygiene during healing
• Adjunctive use alongside silver dressings for partial-thickness burns
• Post-debridement wound cleansing in minor burn cases
• Pediatric burns (surface area appropriate) where minimizing pain on application is critical

HOCl is not a substitute for:

• Emergency burn care protocol (cool running water for 20 minutes)
• Surgical debridement of deep burns
• Intravenous antibiotics for systemic infection
• Tetanus immunization review
• Specialist burn center consultation for large surface area injuries

Frequently Asked Questions

Is HOCl safe to use on children’s burns?

Yes, with appropriate supervision. Stabilized HOCl formulations demonstrate no significant cytotoxicity at therapeutic concentrations and are typically well-tolerated by pediatric patients. The painless application is an advantage in children, where compliance with antiseptic protocols that sting is challenging. A pre-use check with a clinician is always recommended, and any extensive pediatric burn requires medical evaluation regardless of topical agent choice.

Can HOCl be used on blisters?

For intact blisters in partial-thickness burns: HOCl can be applied around the blister and indirectly through the fluid if the blister roof has a small fenestration. For deroofed blisters, HOCl can be applied directly to the exposed basal layer. Always follow local clinical wisdom on blister management — protocols vary between burn services.

How often should HOCl be applied to a healing burn?

For the first 5–7 days post-injury, twice daily application is typical, with dose adjustments based on wound exudate levels. Highly exudative wounds may benefit more from increased application frequency; dry, healing wounds once daily is often sufficient. As re-epithelialization proceeds, application can be reduced.

Does HOCl interact with other wound-care products?

HOCl can be used before or after application of emollients, though waiting approximately 60 seconds between HOCl application and other topicals allows maximal antimicrobial activity. Some practitioners apply HOCl first, wait one minute, then apply prescribed wound ointments. Sequential application (rather than mixing) is advised.

What does the evidence say about HOCl versus silver dressings for burns?

There is limited head-to-head clinical data directly comparing HOCl to silver sulfadiazine for burn wounds. From the safety literature, evidence suggests comparable antimicrobial activity with less cytotoxicity for HOCl — though silver dressings continue to have an established role in many burn-care protocols. The two agents may be used in sequence: HOCl for wound hygiene and moisture management, silver dressings for sustained antimicrobial action on higher-risk wounds.

Can HOCl be used on electrical or chemical burns?

Yes. Electrical burns require specialist evaluation due to deep tissue injury, but surface wound care with HOCl on the entry and exit points is appropriate. Chemical burns should be irrigated copiously with water first, then assessed clinically. HOCl is not indicated when a chemical reaction is still active on the tissue surface — complete irrigation takes priority.

Is there pain on application?

Stabilized HOCl formulations are designed to be painless on application. Unlike alcohol-based products or hydrogen peroxide, HOCl does not activate pain receptors at therapeutic concentrations. Patients who experience stinging should check product integrity (expired or improperly stored formulations may have pH drift) and consult a clinician if symptoms persist.

About Spray8

Spray8 is a HOCl-based wound-care formulation developed by Furley Bioextracts. It is designed for use in minor wound management, skin conditioning, and situations where a non-toxic antimicrobial is needed. For more information on wound-care formulations and skin-care products, visit our wound care and skin treatment pages.

This article is for informational purposes and does not constitute medical advice. Patients with significant burns, signs of infection, or uncertainty about wound depth should seek professional clinical evaluation. Always follow local burn-care protocols for definitive management.